The toxic effect of lithium ion on neurons (PC12 cells) and Aβ42 molecules

Biological Trace Element Research

Volumn 159, Issue 1-3, 2014, Pages 410-415

  Yang, Wang ^a,b   Yan, Zhang ^b   Zhang, Hongjing ^a   Liu, Dexiang ^a   Liu, Zengxun ^b   Cheng, Xiaojing ^b   Yi, Lu ^b   Jia, Jichao ^a   Liu, Jintong ^a,b   Fang, Pan ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shandong Mental Health Center   (China)

Author keywords

Cytotoxicity; Fibril; Lithium; Neurotoxicity

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; LITHIUM CARBONATE; MONOMER; OLIGOMER; THIOFLAVINE; AMYLOID BETA PROTEIN; LITHIUM;

ANIMAL CELL; ARTICLE; ATOMIC FORCE MICROSCOPY; BETA SHEET; CIRCULAR DICHROISM; CONCENTRATION RESPONSE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG PROTEIN BINDING; FLUORESCENCE; FLUORESCENCE ANALYSIS; MOLECULE; MTT ASSAY; NEUROTOXICITY; NONHUMAN; PC12 CELL LINE; PROTEIN AGGREGATION; PROTEIN FIBRILLATION; PROTEIN FUNCTION; PROTEIN INTERACTION; QUENCHING EFFECT; RAT; ANIMAL; DRUG EFFECTS; METABOLISM; NERVE CELL; TOXICITY;

AMYLOID BETA-PEPTIDES; ANIMALS; LITHIUM; MICROSCOPY, ATOMIC FORCE; NEURONS; PC12 CELLS; RATS;

EID: 84902536463     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-9949-z     Document Type: Article

References (22)

1. Coppen A (1999) Editorial - 50 years of lithium treatment of mood disorders. Bipolar Disord 1:3-4
2. Del Grande C, Musetti L, Marazziti D, Muti M, Corsini GU, Dell'Osso L (2013) Lithium monotherapy versus lithium and valproate in manic and mixed states: correlation between serum lithium levels and treatment response. Eur Neuropsychopharmacol 23(2):375
3. Maj M (2004) The impact of lithium prophylaxis on the course of bipolar disorder: a review of the research evidence. Bipolar Disord 2:93-101
4. Lakshmi N, Konstantinos N, Rahman Z et al (2013) Efficacy of aripiprazole versus placebo as adjuncts to lithium or valproate in relapse prevention of manic or mixed episodes in bipolar I patients stratified by index manic or mixed episode. J Affect Disord 147:365-372
5. Lin YF, Huang MC, Liu HC (2013) Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium. J Affect Disord 147:401-406
6. Soares JC, Gershon S (1998) The lithium ion: a foundation for psychopharmacological specificity. Neuropsychopharmacology 19:167-182 (Pubitemid 28302573)
7. Hanson ND, Nemeroff CB, Owens MJ (2011) Lithium, but not fluoxetine or the corticotropin-releasing factor receptor 1 receptor antagonist r121919, increases cell proliferation in the adult dentate gyrus. J Pharmacol Exp Ther 337:180-186
8. Renshaw PF, Wicklund S (1988) In vivo measurement of lithium in humans by nuclear magnetic spectroscopy. Biol Psychiatry 23:465-475 (Pubitemid 18064895)
9. Komoroski RA, Newton JEO, Walker E et al (1990) In vivo NMR spectroscopy of lithium-7 in humans. Magn Reson Med 16:347-356 (Pubitemid 20309331)
10. Kato T, Takahashi S, Inubushi T (1992) Brain lithium concentration by 7Li- and 1H-mangetic resonance spectroscopy in bipolar disorder. Psychiatr Res-Neuroim 45:53-63
11. Barnham KJ, Smith DG, Cappai R (2007) The redox chemistry of the Alzheimer's disease amyloid beta peptide. BBA-Biomembranes 1768:1976-1990 (Pubitemid 47125850)
12. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW (1991) In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res 563:311-314
13. Anne M, Justin A, Nicholas S, David R (2014) Simulations of monomeric amyloid β-peptide (1-40) with varying solution conditions and oxidation state of Met35: implications for aggregation. Arch Biochem Biophys 545:44-52
14. Biancalana M, Koide S (2010) Molecular mechanism of thioflavin-T binding to amyloid fibrils. BBA-Proteins Proteom 1804:1405-1412
15. Krebs MRH, Bromley EHC, Donald AM (2005) The binding of thioflavin-T to amyloid fibrils: localisation and implications. J Struct Biol 149:30-37 (Pubitemid 40051399)
16. Ulrih NP, Barry CH, Fink AL (2008) Impact of Tyr to Ala mutations on alpha-synuclein fibrillation and structural properties. BBA-Mol Basis Dis 1782:581-585
17. Miura T, Suzuki K, Kohata N, Takeuchi H (2000) Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes. Biochemistry-Us 39:7024-7031 (Pubitemid 30390396)
18. Zatta P, Ricchelli F, Drago D, Filippi B, Tognon G (2005) Aluminum-triggered structural modifications and aggregation of beta-amyloids. Cell Mol Life Sci 62:1724-1733 (Pubitemid 41176053)
19. Jiang T, Wang L, Zhang S, Sun PC, Ding CF, Chu YQ, Ping Z (2011) Interaction of curcumin with Al(III) and its complex structures based on experiments and theoretical calculations. J Mol Struct 1004:163-173
20. Akitt JW, Gessner W (1984) Aluminum-27 nuclear magnetic resonance investigations of highly alkaline aluminate solutions. J Chem Soc Dalton 147-148
21. Drago D, Bettella M, Bolognin S, Cendron L, Scancar J, Milacic R, Ricchelli F, Casini A, Messori L, Tognon G, Zatta P (2008) Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's disease. Int J Biochem Cell Biol 40:731-746 (Pubitemid 351288594)
22. Besseling NAM, Lyklema J (1997) Molecular thermodynamics of hydrophobic hydration. J Phys Chem B 101:7604-7611 (Pubitemid 127581208)